Exciting News About Our Clinical Trial: Learn More

Exciting News About Our Clinical Trial: Learn More

Buy Now
 | Checkout

The Chemo Mouthpiece Clinical Trial

The Chemo Mouthpiece Clinical Research Trial

Chemo Mouthpiece LLC.  has engaged world renowned Oral Mucositis expert, Dr. Steve Sonis (currently with Harvard, Dana-Farber Cancer Institute and Brigham & Women’s Hospital), to lead our clinical research trial.  This trial is assessing the efficacy and utility of our novel oral cryotherapy delivery device, the Chemo Mouthpiece™ (CMP™).  Specifically, we are assessing the ability of the CMP™ to mitigate symptoms associated with chemotherapy-induced oral mucositis in cancer patients being treated with standard mucotoxic chemotherapy regimens for many varied tumor types. This is a post-marketing, randomized, prospective, multi-site trial conducted within the United States.  Ten top cancer institutes have been enlisted to participate in this clinical trial; these sites are located in California, Indiana, Missouri, Manhattan as well as New York State, Ohio, South Carolina, and Michigan.  The trial commenced in August 2020 with a planned accrual of 200 patients.  These patients are randomized to either the Chemo Mouthpiece™ Arm or the Best Supportive Oral Care Arm.

The full list of participating sites as well as a synopsis of the clinical trial can be found at: https://clinicaltrials.gov/ct2/show/NCT04595838.